Lakers and Clippers guard, were sentenced to prison for stealing up to $5.1-million worth of U.S. Postal Service money orders ...

ANSWER: Whether stents are beneficial in people with stable coronary artery disease remains somewhat controversial. Although ...

SpectraWAVE, Inc., a medical imaging company focused on improving the treatment and outcomes for patients with coronary artery disease (CAD), today an ...

Boston Scientific is diving into the field of intravascular lithotripsy, with a $664 million deal to pick up Bolt Medical and ...

The wife and three sons of David Walters asserted in a June 2021 lawsuit that chemicals he inhaled and was exposed to during ...

Coronary artery disease (CAD) is common in patients with cirrhosis, but cirrhosis itself is not significantly associated with an increased CAD risk.

Boston Scientific to acquire Bolt Medical for $600 million upfront plus milestones. Bolt's IVL platform addresses coronary ...

The company is trying to develop a one-time treatment for forms of heart disease that afflict more than 1 million people in ...

Individuals with early-onset COPD and rapidly progressive pre-COPD frequently have a decades-long history of impaired ...

Trientine hydrochloride is under clinical development by Innolife and currently in Phase II for Coronary Artery Disease (CAD) (Ischemic Heart Disease).

Boston Scientific (NYSE: BSX) announced today that it agreed to acquire intravascular lithotripsy (IVL) platform developer ...

Boston Scientific Corp. (BSX) announced on Wednesday its agreement to acquire the remaining 74 percent stake in Bolt Medical, Inc., ...